OmniAb, Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
OABI$5.10-3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating activities: | ||
| Net loss | $(13,566) | $(34,075) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation of property and equipment | 1,183 | 1,830 |
| Amortization of intangible assets | 9,081 | 6,456 |
| Amortization of operating lease right-of-use assets | 1,168 | 1,106 |
| Share-based compensation | 6,499 | 8,255 |
| Amortization of discounts on short-term investments, net | (344) | (442) |
| Deferred income taxes, net | 97 | 13 |
| Change in estimated fair value of contingent liabilities | (281) | 225 |
| Gain on sale of ion channel asset | — | (3,000) |
| Other | 63 | 120 |
| Changes in operating assets and liabilities, net: | ||
| Accounts receivable, net | (2,554) | 2,599 |
| Prepaid expenses and other current assets | 236 | 135 |
| Other long-term assets | 211 | 374 |
| Accounts payable, accrued expenses, and other liabilities | (1,545) | (1,771) |
| Operating lease liabilities | (1,505) | (1,381) |
| Deferred revenue | (978) | (1,462) |
| Net cash used in operating activities | (2,235) | (21,018) |
| Investing activities: | ||
| Purchases of short-term investments | (33,009) | (18,595) |
| Proceeds from the maturity of short-term investments | 34,100 | 27,300 |
| Purchases of property and equipment | (277) | (374) |
| Proceeds from sale of short-term investments | — | 90 |
| Proceeds from sale of ion channel asset | — | 3,000 |
| Net cash provided by investing activities | 814 | 11,421 |
| Financing activities: | ||
| Payment of contingent liabilities | (113) | — |
| Proceeds from issuance of common stock from stock plans | 346 | 341 |
| Payment of transaction costs | — | (61) |
| Net cash provided by financing activities | 233 | 280 |
| Net change in cash, cash equivalents and restricted cash | (1,188) | (9,317) |
| Cash, cash equivalents and restricted cash at beginning of period | 26,084 | 28,158 |
| Cash, cash equivalents and restricted cash at end of period | $24,896 | $18,841 |
| Supplemental cash flow information: | ||
| Deferred revenue recorded in accounts receivable | $384 | $33 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.